Products
Piracetam ABR 1 200 mg powder for oral solution in sachet
Generic name: | Piracetam |
АТС code: | N06BX03 |
Composition: | 1 sachet powder for oral solution contains 1 200 mg Piracetam. |
Group: | Nervous system, Psychostimulants |
Subgroup: Other psychostimulants and nootropics
Medical product subject to medical prescription
Route (s) of administration: Oral use
Nature and contents of container: The product is packed in sachets of paper / aluminum / polyethylene, placed in carton box, 10, 20, 30, 50, 60 and 100 sachets each.
Description/Indications:
Piracetam ABR belongs to the group of nootropic medicinal products, derivates of gamma-butyric acid. Piracetam ABR improves and restores disturbances in cognitive processes (learning ability, memory, attention and mental performance) due to brain diseases and intoxication (poisoning). It has no calming and psycho-stimulating effect. Piracetam ABR improves the rheological properties (blood flow) of the blood.
Piracetam ABR is used in:
Adults
- To improve memory and attention disorders, as well as loss of motivation due to brain diseases and impairments (so-called psycho-organic syndrome);
- For the treatment of sudden, involuntary muscle contractions (so-called cortical (core) myoclonus), alone or in combination with other medicines;
- For the treatment of vertigo and related disturbances of balance, except for dizziness of vascular or mental origin;
- For the prevention and remission of sickle cell vaso-occlusive crisis (the so-called vascular crisis - obstruction of the small blood vessels) in sickle cell anaemia (a hereditary disease in which the structure of haemoglobin is disturbed and the shape of red blood cells is altered).
Children
- Treatment of speech disorders (dyslexia), in combination with other appropriate measures such as speech therapy;
- For the prevention and remission of sickle cell vaso-occlusive crisis.
Products manufactured under contract
Generic name | Pharmaceutical form | АТС code |
---|---|---|
Acetylsalicylic acid | Tablets 500 mg | C01DA05 |
Azithromycin | Hard capsules 250 mg | J01FA10 |
Azithromycin | Powder for oral suspension 100 mg/5 ml, 20 ml | J01FA10 |
Azithromycin | Powder for oral suspension 200 mg/5 ml, 20 ml | J01FA10 |
Bifonazole | Cream 1%, 15 g | D01AC10 |
Chloramphenicol | Hard capsules 250 mg | J01BA01 |
Chloramphenicol | Ointment 2 %, 20 g | D06AX02 |
Cinnarizine | Tablets 25 mg | N07CA02 |
Clindamycin | Hard capsules 150 mg | J01FF01 |
Clobetasol propionate | Ointment 0,5 mg/g, 15 g | D07AD01 |
Clobetasol propionate | Cream 0,5 mg/g, 15 g | D07AD01 |
Dequalinium chloride; Ascorbic acid | Compressed lozenges | C01DA05 |
Dexamethasone, Tobramycin | Eye drops, suspension 3 mg/ml + 1 mg/ml, 5 ml | S01CA01 |
Dimenhydrinate | Tablets 50 mg | R06AA00 |
Doxycyclin | Hard capsules 100 mg | J01AA02 |
Fluconazole | Hard capsules 50 mg | J02AC01 |
Fluconazole | Hard capsules 100 mg | J02AC01 |
Fluocinolone acetonide | Ointment 0,25 mg/g, 15 g | D07AC04 |
Fluocinolone acetonide | Cream 0,25 mg/g, 15 g | D07AC04 |
Fluocinolone acetonide, Neomycin | Cream 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
Fluocinolone acetonide, Neomycin | Ointment 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
Gentamicin | Cream 1 mg/g, 15 g | D06AX07 |
Gentamicin | Ointment 1 mg/g, 15 g | D06AX07 |
Gentamicin, Hydrocortisone | Cream 1 mg/g + 10 mg/g, 15 g | D07CA01 |
Gentamicin, Hydrocortisone | Ointment 1 mg/g + 10 mg/g, 15 g | D07CA01 |
Hydrochlorothiazide | Tablets 25 mg | C03AA03 |
Hydrocortisone, Chloramphenicol | Eye drops, suspension 10 mg/ml + 2 mg/ml, 5 ml | S01CA03 |
Hydrocortisone, Neomycin | Cream 10 mg/g + 3,5 mg/g, 15 g | D07CA01 |
Hydrocortisone, Neomycin | Ointment 25 mg/g + 25 mg/g, 10 g | D07CA01 |
Indapamide hemihydrate | Film-coated tablets 2,5 mg | C03BA11 |
Isosorbide dinitrate | Prolonged-realese tablets 20 mg | C01DA08 |
Isosorbide dinitrate | Tablets 10 mg | C01DA08 |
Lincomycin | Hard capsules 500 mg | J01FF02 |
Lovastatin | Tablets 20 mg | C10AA02 |
Lovastatin | Tablets 40 mg | C10AA02 |
Magnesium DL-aspartate tetrahydrate, Potassium DL-aspartate hemihydrate | Film-coated tablets 175 mg + 166 mg | A12BA30 |
Metamizole sodium, Thiamine hydrochloride, Caffeine | Tablets 500 mg + 50 mg + 38,75 mg | N02BB52 |
Nystatin | Cream 100 000 IU/g, 15 g | D01AA01 |
Nystatin | Ointment 100 000 IU/g, 15 g | D01AA01 |
Nystatin | Tablets 500 000 IU | A07AA02 |
Oleandomycin, Dexamethasone, Indometacin | Oromucisal paste 50 mg/g + 10 mg/g + 50 mg/g, 5 ml | A01AD11 |
Papaverine hydrochloride | Tablets 50 mg | A03AD01 |
Pentaerithrityl tetranitrate | Tablets 10 mg | C01DA05 |
Piracetam | Film-coated tablets 800 mg | N06BX03 |
Piracetam | Hard Capsules 400 mg | N06BX03 |
Propranolol hydrochloride | Tablets 20 mg | C07AA05 |
Propranolol hydrochloride | Tablets 40 mg | C07AA05 |
Rifampicin | Hard capsules 300 mg | J04AB02 |
Tetracycline | Hard capsules 250 mg | J01AA07 |
Tetracycline | Ointment 3 %, 20 g | D06AA04 |
Tobramycin | Eye drops, solution 0,3 %, 5 ml | S01AA12 |
Triamterene, Hydrochlorothiazide | Tablets 25 mg + 12,5 mg | C03EA01 |
Troxerutin | Hard capsules 300 mg | C05CA04 |
New products
Aciclovir Vision 30 mg/g eye ointment
Subgroup: Antiinfectives, Antiviral products Medical product subject to medical prescription Route (s) of administration: Ocular use Nature and contents of container: The medicinal product is packe...
MorePrednisolon F 2 mg tablets
Subgroup: Glucocorticoids Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: 10 (ten) tablets are packed in a PVC / PVdC / AL fo...
MoreInosipranol 500 mg and 1000 mg powder for oral solution
Subgroup: Direct acting antivirals, Other antivirals Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: Inosipranol 500 m...
MoreClindavasin D 10 mg/ml cutaneous solution
Indications: Clindavasin D 10 mg/ml cutaneous solution is used to apply to the skin to treat acne vulgaris. Medical product subject to medical prescription Route (s) of administration: Clindavasin D...
More